Atomo Diagnostics Ltd Net Assets

Latest as of December 2025: AU$6.64 Million AUD ≈ $4.70 Million USD

Atomo Diagnostics Ltd net assets. Based on the latest financial reports, Atomo Diagnostics Ltd (AT1) has net assets worth AU$6.64 Million AUD (≈ $4.70 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$9.48 Million ≈ $6.71 Million USD) and total liabilities (AU$2.84 Million ≈ $2.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Atomo Diagnostics Ltd growing its equity to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$6.64 Million
% of Total Assets	70.09%
Annual Growth Rate	86.42%
5-Year Change	-76.81%
10-Year Change	N/A
Growth Volatility	3837.19

Net Assets of Atomo Diagnostics Ltd (2017–2025)

Net assets of Atomo Diagnostics Ltd from 2017 to 2025. This chart illustrates how Atomo Diagnostics Ltd's net assets have evolved over time, based on quarterly financial data. See AT1 equity to assets ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Atomo Diagnostics Ltd (2017–2025)

The table below shows the annual net assets of Atomo Diagnostics Ltd from 2017 to 2025. For live market cap and overall valuation, see AT1 market cap.

Year	Net Assets	Change
2025-06-30	AU$6.98 Million ≈ $4.94 Million	-30.83%
2024-06-30	AU$10.08 Million ≈ $7.14 Million	-31.82%
2023-06-30	AU$14.79 Million ≈ $10.47 Million	-40.40%
2022-06-30	AU$24.81 Million ≈ $17.56 Million	-17.53%
2021-06-30	AU$30.09 Million ≈ $21.29 Million	-12.74%
2020-06-30	AU$34.48 Million ≈ $24.40 Million	+730.18%
2019-06-30	AU$-5.47 Million ≈ $-3.87 Million	-11.93%
2018-06-30	AU$-4.89 Million ≈ $-3.46 Million	-10322.88%
2017-06-30	AU$47.82K ≈ $33.83K	--

Equity Component Analysis

This analysis shows how different components contribute to Atomo Diagnostics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 5179835600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Atomo Diagnostics Ltd Net Assets Breakdown (June 2025)

Atomo Diagnostics Ltd net assets breakdown by equity component as of June 2025.

Component	Amount	Percentage
Common Stock	AU$71.84 Million	1029.82%
Other Comprehensive Income	AU$91.75K	1.32%
Total Equity	AU$6.98 Million	100.00%

Atomo Diagnostics Ltd Competitors by Market Cap

The table below lists competitors of Atomo Diagnostics Ltd ranked by their market capitalization.

Company	Market Cap
Nakoda Group of Industries Limited NSE:NGIL	$8.30 Million
Mont Royal Resources Ltd AU:MRZ	$8.31 Million
Yorkton Equity Group Inc V:YEG	$8.31 Million
HYDROGEN UTOPIA INT.-001 F:D60	$8.31 Million
IP Group LSE:IPO	$8.30 Million
Workspace Group PLC LSE:WKP	$8.29 Million
Trinseo SA NYSE:TSE	$8.28 Million
Willamette Valley Vineyards Inc NASDAQ:WVVI	$8.27 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Atomo Diagnostics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 10,084,619 to 6,975,816, a change of -3,108,803 (-30.8%).
Net loss of 4,970,934 reduced equity.
New share issuances of 1,652,838 increased equity.
Other comprehensive income increased equity by 3,349.
Other factors increased equity by 205,944.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-4.97 Million	-71.26%
Share Issuances	AU$1.65 Million	+23.69%
Other Comprehensive Income	AU$3.35K	+0.05%
Other Changes	AU$205.94K	+2.95%
Total Change	AU$-	-30.83%

Book Value vs Market Value Analysis

This analysis compares Atomo Diagnostics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.21x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 152.49x to 1.21x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-06-30	AU$0.00	AU$0.01	x
2018-06-30	AU$-0.01	AU$0.01	x
2019-06-30	AU$-0.01	AU$0.01	x
2020-06-30	AU$0.10	AU$0.01	x
2021-06-30	AU$0.05	AU$0.01	x
2022-06-30	AU$0.04	AU$0.01	x
2023-06-30	AU$0.03	AU$0.01	x
2024-06-30	AU$0.02	AU$0.01	x
2025-06-30	AU$0.01	AU$0.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Atomo Diagnostics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -71.26%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -131.08%
• Asset Turnover: 0.41x
• Equity Multiplier: 1.33x
Recent ROE (-71.26%) is above the historical average (-1226.98%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2017	-10766.62%	-1745.65%	0.02x	248.20x	AU$-5.15 Million
2018	0.00%	-1705.89%	0.04x	0.00x	AU$-4.41 Million
2019	0.00%	-936.59%	0.09x	0.00x	AU$-4.51 Million
2020	-26.73%	-171.70%	0.15x	1.05x	AU$-12.67 Million
2021	-20.01%	-89.66%	0.21x	1.07x	AU$-9.03 Million
2022	-23.00%	-46.26%	0.46x	1.07x	AU$-8.19 Million
2023	-67.33%	-391.46%	0.15x	1.11x	AU$-11.44 Million
2024	-67.90%	-167.57%	0.36x	1.13x	AU$-7.86 Million
2025	-71.26%	-131.08%	0.41x	1.33x	AU$-5.67 Million

Industry Comparison

This section compares Atomo Diagnostics Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $90,521,161
Average return on equity (ROE) among peers: -226.76%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Atomo Diagnostics Ltd (AT1)	AU$6.64 Million	-10766.62%	0.43x	$8.30 Million
4DMEDICAL Ltd (4DX)	$4.56 Million	-142.48%	0.98x	$962.19 Million
Adherium Ltd (ADR)	$6.48 Million	-157.77%	0.53x	$2.02 Million
Aroa Biosurgery Ltd (ARX)	$9.34 Million	0.00%	0.17x	$121.45 Million
Avita Medical Inc (AVH)	$4.50 Million	-1374.64%	16.72x	$188.51 Million
Anteris Technologies Global Corp (AVR)	$28.66 Million	-234.92%	0.59x	$582.48 Million
Control Bionics Ltd (CBL)	$17.16 Million	-20.69%	0.07x	$19.21 Million
Cardiex Ltd (CDX)	$6.61 Million	-172.18%	0.87x	$13.23 Million
Compumedics Ltd (CMP)	$11.48 Million	23.76%	0.87x	$35.34 Million
Cochlear Ltd (COH)	$725.90 Million	38.12%	0.90x	$6.97 Billion

About Atomo Diagnostics Ltd

AU:AT1 Australia Medical Devices

Market Cap

$8.30 Million

AU$11.73 Million AUD

Market Cap Rank

#27368 Global

#1317 in Australia

Share Price

AU$0.01

Change (1 day)

+8.33%

52-Week Range

AU$0.01 - AU$0.04

All Time High

AU$0.57